{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:10:34Z","timestamp":1782828634457,"version":"3.54.5"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Thyroid cancer (TC) patients are understudied but appear to be at risk for poor physical and psychosocial outcomes. Knowledge of the course and determinants of these deteriorated outcomes is lacking. Furthermore, little is known about mediating biological mechanisms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The WaTCh-study aims to;<\/jats:p><jats:p><jats:list list-type=\"order\"><jats:list-item><jats:p>Examine the course of physical and psychosocial outcomes.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Examine the association of demographic, environmental, clinical, physiological, and personality characteristics to those outcomes. In other words,<jats:italic>who<\/jats:italic>is at risk?<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Reveal the association of mediating biological mechanisms (inflammation, kynurenine pathway) with poor physical and psychological outcomes. In other words,<jats:italic>why<\/jats:italic>is a person at risk?<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p><\/jats:sec><jats:sec><jats:title>Design and methods<\/jats:title><jats:p>Newly diagnosed TC patients from 13 Dutch hospitals will be invited. Data collection will take place before treatment, and at 6, 12 and 24\u00a0months after diagnosis. Sociodemographic and clinical information is available from the Netherlands Cancer Registry. Patients fill-out validated questionnaires at each time-point to assess quality of life, TC-specific symptoms, physical activity, anxiety, depression, health care use, and employment. Patients are asked to donate blood three times\u00a0to assess inflammation and kynurenine pathway. Optionally, at each occasion, patients can use a weighing scale with bioelectrical impedance analysis (BIA) system to assess body composition;\u00a0can register food intake using an online food diary;\u00a0and can wear an activity tracker to assess physical activity and sleep duration\/quality. Representative Dutch normative data on the studied physical and psychosocial outcomes is already available.<\/jats:p><\/jats:sec><jats:sec><jats:title>Impact<\/jats:title><jats:p>WaTCh will reveal the course of physical and psychosocial outcomes among TC patients over time and answers the question<jats:italic>who<\/jats:italic>is at risk for poor outcomes, and<jats:italic>why.<\/jats:italic>This knowledge can be used to provide personalized information, to improve screening, to develop and provide tailored treatment strategies and supportive care, to optimize outcomes, and ultimately increase the number of TC survivors that live in good health.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13044-023-00165-5","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:01:41Z","timestamp":1688947301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study"],"prefix":"10.1186","volume":"16","author":[{"given":"Floortje","family":"Mols","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dounya","family":"Schoormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Netea-Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Beijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrijn","family":"Van Deun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Zandee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Kars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pleun C. M.","family":"Wouters van Poppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suat","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"van Battum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me M. H.","family":"Kisters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Paul","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elske","family":"Massolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"van Leeuwaarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Oranje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Roerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechteld","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke","family":"van de Poll-Franse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"issue":"6","key":"165_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374\u2013403.","journal-title":"Eur J Cancer"},{"issue":"11","key":"165_CR2","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1089\/thy.2012.0573","volume":"23","author":"B Amphlett","year":"2013","unstructured":"Amphlett B, et al. Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985\u20132010. Thyroid. 2013;23(11):1470\u20138.","journal-title":"Thyroid"},{"issue":"2","key":"165_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/ERC-12-0336","volume":"20","author":"O Husson","year":"2013","unstructured":"Husson O, et al. Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989. Endocr Relat Cancer. 2013;20(2):263\u201371.","journal-title":"Endocr Relat Cancer"},{"key":"165_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12885-016-2429-4","volume":"16","author":"M Carlberg","year":"2016","unstructured":"Carlberg M, et al. Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data. BMC Cancer. 2016;16:426.","journal-title":"BMC Cancer"},{"issue":"7","key":"165_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jamaoto.2016.0230","volume":"142","author":"LG Morris","year":"2016","unstructured":"Morris LG, Tuttle RM, Davies L. Changing Trends in the Incidence of Thyroid Cancer in the United States. JAMA Otolaryngol Head Neck Surg. 2016;142(7):709\u201311.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"9340","key":"165_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","volume":"360","author":"H Brenner","year":"2002","unstructured":"Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet. 2002;360(9340):1131\u20135.","journal-title":"Lancet"},{"issue":"8","key":"165_CR7","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.ejrad.2011.04.028","volume":"81","author":"LM Wu","year":"2012","unstructured":"Wu LM, et al. The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: A meta-analysis. Eur J Radiol. 2012;81(8):1798\u2013805.","journal-title":"Eur J Radiol"},{"key":"165_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7150\/jca.2.193","volume":"2","author":"RL Brown","year":"2011","unstructured":"Brown RL, de Souza JA, Cohen EE. Thyroid cancer: burden of illness and management of disease. J Cancer. 2011;2:193\u20139.","journal-title":"J Cancer"},{"issue":"6","key":"165_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.clon.2010.05.002","volume":"22","author":"F Pacini","year":"2010","unstructured":"Pacini F, et al. Medullary thyroid carcinoma. Clin Oncol (R Coll Radiol). 2010;22(6):475\u201385.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"Suppl 5","key":"165_CR10","doi-asserted-by":"publisher","first-page":"v214","DOI":"10.1093\/annonc\/mdq190","volume":"21","author":"F Pacini","year":"2010","unstructured":"Pacini F, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v214\u20139.","journal-title":"Ann Oncol"},{"issue":"32","key":"165_CR11","first-page":"1777","volume":"151","author":"TP Links","year":"2007","unstructured":"Links TP, et al. Guideline \u201cDifferentiated thyroid carcinoma\u201d, including diagnosis of thyroid nodules. Ned Tijdschr Geneeskd. 2007;151(32):1777\u201382.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"4","key":"165_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1365-2265.2011.04114.x","volume":"75","author":"O Husson","year":"2011","unstructured":"Husson O, et al. Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endocrinol (Oxf). 2011;75(4):544\u201354.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"165_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00268-015-3300-5","volume":"40","author":"MK Applewhite","year":"2016","unstructured":"Applewhite MK, et al. Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival. World J Surg. 2016;40(3):551\u201361.","journal-title":"World J Surg"},{"issue":"8","key":"165_CR14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00259-015-3022-9","volume":"42","author":"EM Gamper","year":"2015","unstructured":"Gamper EM, et al. Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme. Eur J Nucl Med Mol Imaging. 2015;42(8):1179\u201388.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"165_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1530\/eje.1.02310","volume":"156","author":"LH Duntas","year":"2007","unstructured":"Duntas LH, Biondi B. Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. Eur J Endocrinol. 2007;156(1):13\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"165_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/thy.1997.7.613","volume":"7","author":"KH Dow","year":"1997","unstructured":"Dow KH, Ferrell BR, Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid. 1997;7(4):613\u20139.","journal-title":"Thyroid"},{"issue":"5","key":"165_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1530\/EJE-06-0724","volume":"156","author":"I Borget","year":"2007","unstructured":"Borget I, et al. Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal. Eur J Endocrinol. 2007;156(5):531\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"165_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00520-003-0474-4","volume":"11","author":"R Crevenna","year":"2003","unstructured":"Crevenna R, et al. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Cancer. 2003;11(9):597\u2013603.","journal-title":"Support Care Cancer"},{"issue":"3","key":"165_CR19","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1210\/jc.2005-2064","volume":"91","author":"PR Schroeder","year":"2006","unstructured":"Schroeder PR, et al. A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab. 2006;91(3):878\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"165_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/0284186X.2012.723822","volume":"52","author":"SH Roerink","year":"2013","unstructured":"Roerink SH, et al. High level of distress in long-term survivors of thyroid carcinoma: results of rapid screening using the distress thermometer. Acta Oncol. 2013;52(1):128\u201337.","journal-title":"Acta Oncol"},{"issue":"2","key":"165_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/0284186X.2012.741326","volume":"52","author":"O Husson","year":"2013","unstructured":"Husson O, et al. Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol. 2013;52(2):249\u201358.","journal-title":"Acta Oncol"},{"issue":"2","key":"165_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/thy.2011.0139","volume":"22","author":"S Singer","year":"2012","unstructured":"Singer S, et al. Quality of Life in Patients with Thyroid Cancer Compared with the General Population. Thyroid. 2012;22(2):117\u201324.","journal-title":"Thyroid"},{"issue":"2","key":"165_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11764-020-00923-6","volume":"15","author":"CS Bonhof","year":"2021","unstructured":"Bonhof CS, et al. The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients. J Cancer Surviv. 2021;15(2):190\u2013200.","journal-title":"J Cancer Surviv"},{"issue":"6","key":"165_CR24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1200\/JCO.2016.69.7946","volume":"35","author":"O Husson","year":"2017","unstructured":"Husson O, et al. Health-Related Quality of Life in Adolescent and Young Adult Patients With Cancer: A Longitudinal Study. J Clin Oncol. 2017;35(6):652\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"165_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jso.23345","volume":"108","author":"S Misra","year":"2013","unstructured":"Misra S, et al. Patients\u2019 experiences following local-regional recurrence of thyroid cancer: a qualitative study. J Surg Oncol. 2013;108(1):47\u201351.","journal-title":"J Surg Oncol"},{"issue":"12","key":"165_CR26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.4065\/81.12.1545","volume":"81","author":"S Kung","year":"2006","unstructured":"Kung S, et al. Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers. Mayo Clin Proc. 2006;81(12):1545\u201352.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"165_CR27","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1089\/thy.2015.0098","volume":"25","author":"B Aschebrook-Kilfoy","year":"2015","unstructured":"Aschebrook-Kilfoy B, et al. Risk Factors for Decreased Quality of Life in Thyroid Cancer Survivors: Initial Findings from the North American Thyroid Cancer Survivorship Study. Thyroid. 2015;25(12):1313\u201321.","journal-title":"Thyroid"},{"issue":"13","key":"165_CR28","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.7314\/APJCP.2014.15.13.5287","volume":"15","author":"KT Han","year":"2014","unstructured":"Han KT, et al. Associations between quality of life and marital status in cancer patients and survivors. Asian Pac J Cancer Prev. 2014;15(13):5287\u201391.","journal-title":"Asian Pac J Cancer Prev"},{"key":"165_CR29","doi-asserted-by":"publisher","unstructured":"Verhaar S, Vissers PA, Maas H, van de Poll-Franse LV, van Erning FN, Mols F. Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: results from the population-based PROFILES registry. Eur J Cancer. 2015;51(10):1263\u201373. https:\/\/doi.org\/10.1016\/j.ejca.2015.04.004.","DOI":"10.1016\/j.ejca.2015.04.004"},{"issue":"10","key":"165_CR30","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/hed.25325","volume":"40","author":"F Mols","year":"2018","unstructured":"Mols F, et al. Age-related differences in health-related quality of life among thyroid cancer survivors compared with a normative sample: Results from the PROFILES Registry. Head Neck. 2018;40(10):2235\u201345.","journal-title":"Head Neck"},{"issue":"3","key":"165_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3803\/EnM.2015.30.3.343","volume":"30","author":"SY Sohn","year":"2015","unstructured":"Sohn SY, et al. Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression. Endocrinol Metab (Seoul). 2015;30(3):343\u201351.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"12","key":"165_CR32","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1089\/thy.2010.0393","volume":"21","author":"JT Weinreb","year":"2011","unstructured":"Weinreb JT, Yang Y, Braunstein GD. Do patients gain weight after thyroidectomy for thyroid cancer? Thyroid. 2011;21(12):1339\u201342.","journal-title":"Thyroid"},{"issue":"7","key":"165_CR33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1089\/thy.2010.0052","volume":"21","author":"S Vigario Pdos","year":"2011","unstructured":"Vigario Pdos S, et al. Effects of physical activity on body composition and fatigue perception in patients on thyrotropin-suppressive therapy for differentiated thyroid carcinoma. Thyroid. 2011;21(7):695\u2013700.","journal-title":"Thyroid"},{"issue":"1","key":"165_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12911-020-1064-9","volume":"20","author":"D Revesz","year":"2020","unstructured":"Revesz D, et al. Development and internal validation of prediction models for colorectal cancer survivors to estimate the 1-year risk of low health-related quality of life in multiple domains. BMC Med Inform Decis Mak. 2020;20(1):54.","journal-title":"BMC Med Inform Decis Mak"},{"key":"165_CR35","doi-asserted-by":"publisher","unstructured":"van Veen MR, Mols F, Bours MJL, Weijenberg MP, Kampman E, Beijer S. Adherence to the World Cancer Research Fund\/American Institute for Cancer Research recommendations for cancer prevention is associated with better health-related quality of life among long-term colorectal cancer survivors: results of the PROFILES registry. Support Care Cancer. 2019;27(12):4565\u201374. https:\/\/doi.org\/10.1007\/s00520-019-04735-y.","DOI":"10.1007\/s00520-019-04735-y"},{"issue":"8","key":"165_CR36","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/01635581.2017.1367938","volume":"69","author":"PAJ Vissers","year":"2017","unstructured":"Vissers PAJ, et al. The Impact of Body Mass Index and Waist Circumference on Health-related Quality of Life Among Colorectal Cancer Survivors: Results from the PROFILES Registry. Nutr Cancer. 2017;69(8):1177\u201384.","journal-title":"Nutr Cancer"},{"issue":"6","key":"165_CR37","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00520-015-3052-7","volume":"24","author":"PA Vissers","year":"2016","unstructured":"Vissers PA, et al. Prospectively measured lifestyle factors and BMI explain differences in health-related quality of life between colorectal cancer patients with and without comorbid diabetes. Support Care Cancer. 2016;24(6):2591\u2013601.","journal-title":"Support Care Cancer"},{"issue":"1","key":"165_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ygyno.2012.12.041","volume":"129","author":"CS Oldenburg","year":"2013","unstructured":"Oldenburg CS, et al. The relationship of body mass index with quality of life among endometrial cancer survivors: A study from the population-based PROFILES registry. Gynecol Oncol. 2013;129(1):216\u201321.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"165_CR39","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3109\/0284186X.2014.996664","volume":"54","author":"O Husson","year":"2015","unstructured":"Husson O, et al. High levels of physical activity are associated with lower levels of fatigue among lymphoma patients: Results from the longitudinal PROFILES registry. Acta Oncol. 2015;54(5):678\u201384.","journal-title":"Acta Oncol"},{"key":"165_CR40","doi-asserted-by":"publisher","unstructured":"Oerlemans S, Issa DE, van den Broek EC, Nijziel MR, Coebergh JW, Huijgens PC, Mols F, van de Poll-Franse LV. Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry. Ann Hematol. 2014;93(10):1705\u201315. https:\/\/doi.org\/10.1007\/s00277-014-2099-8.","DOI":"10.1007\/s00277-014-2099-8"},{"issue":"3","key":"165_CR41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3324\/haematol.2012.064907","volume":"98","author":"S Oerlemans","year":"2013","unstructured":"Oerlemans S, et al. A high level of fatigue among long-term survivors of non-Hodgkin\u2019s lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica. 2013;98(3):479\u201386.","journal-title":"Haematologica"},{"issue":"1","key":"165_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11764-017-0641-0","volume":"12","author":"MSY Thong","year":"2018","unstructured":"Thong MSY, et al. Identifying the subtypes of cancer-related fatigue: results from the population-based PROFILES registry. J Cancer Surviv. 2018;12(1):38\u201346.","journal-title":"J Cancer Surviv"},{"issue":"10","key":"165_CR43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s11136-010-9759-5","volume":"19","author":"MA Sprangers","year":"2010","unstructured":"Sprangers MA, et al. Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res. 2010;19(10):1395\u2013403.","journal-title":"Qual Life Res"},{"issue":"7","key":"165_CR44","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s11136-014-0656-1","volume":"23","author":"MA Sprangers","year":"2014","unstructured":"Sprangers MA, et al. Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update. Qual Life Res. 2014;23(7):1997\u20132013.","journal-title":"Qual Life Res"},{"issue":"9","key":"165_CR45","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1210\/jc.2013-1315","volume":"98","author":"PN Taylor","year":"2013","unstructured":"Taylor PN, et al. Clinical review: A review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab. 2013;98(9):3562\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"165_CR46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.med.0000432611.03732.49","volume":"20","author":"L Wartofsky","year":"2013","unstructured":"Wartofsky L. Combination L-T3 and L-T4 therapy for hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2013;20(5):460\u20136.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"165_CR47","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2008-1301","volume":"94","author":"V Panicker","year":"2009","unstructured":"Panicker V, et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009;94(5):1623\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"165_CR48","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1210\/jc.2007-1067","volume":"93","author":"M Torlontano","year":"2008","unstructured":"Torlontano M, et al. Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J Clin Endocrinol Metab. 2008;93(3):910\u20133.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"165_CR49","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1089\/thy.2010.0244","volume":"20","author":"PW Butler","year":"2010","unstructured":"Butler PW, et al. The Thr92Ala 5\u2019 type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study. Thyroid. 2010;20(12):1407\u201312.","journal-title":"Thyroid"},{"issue":"11","key":"165_CR50","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/jnci\/djs207","volume":"104","author":"R Ballard-Barbash","year":"2012","unstructured":"Ballard-Barbash R, et al. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104(11):815\u201340.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"165_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","volume":"273","author":"IB Wilson","year":"1995","unstructured":"Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59\u201365.","journal-title":"JAMA"},{"issue":"4","key":"165_CR52","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1547-5069.2005.00058.x","volume":"37","author":"CE Ferrans","year":"2005","unstructured":"Ferrans CE, et al. Conceptual model of health-related quality of life. J Nurs Scholarsh. 2005;37(4):336\u201342.","journal-title":"J Nurs Scholarsh"},{"issue":"8","key":"165_CR53","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/ni.3754","volume":"18","author":"L Zitvogel","year":"2017","unstructured":"Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer. Nat Immunol. 2017;18(8):843\u201350.","journal-title":"Nat Immunol"},{"issue":"5","key":"165_CR54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/MED.0000000000000556","volume":"27","author":"A Matrone","year":"2020","unstructured":"Matrone A, et al. Obesity as a risk factor for thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2020;27(5):358\u201363.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"165_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"key":"165_CR56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/ijpvm.IJPVM_332_18","volume":"11","author":"H Zahedi","year":"2020","unstructured":"Zahedi H, et al. A Higher Dietary Inflammatory Index Score is Associated with a Higher Risk of Incidence and Mortality of Cancer: A Comprehensive Systematic Review and Meta-Analysis. Int J Prev Med. 2020;11:15.","journal-title":"Int J Prev Med"},{"issue":"5","key":"165_CR57","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","volume":"72","author":"M Muzza","year":"2010","unstructured":"Muzza M, et al. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf). 2010;72(5):702\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"165_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bcp.2014.12.023","volume":"94","author":"D Thapa","year":"2015","unstructured":"Thapa D, Ghosh R. Chronic inflammatory mediators enhance prostate cancer development and progression. Biochem Pharmacol. 2015;94(2):53\u201362.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"165_CR59","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1089\/thy.2013.0015","volume":"23","author":"O Husson","year":"2013","unstructured":"Husson O, et al. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry. Thyroid. 2013;23(10):1247\u201355.","journal-title":"Thyroid"},{"issue":"7","key":"165_CR60","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00520-014-2577-5","volume":"23","author":"O Husson","year":"2015","unstructured":"Husson O, et al. Variation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry. Support Care Cancer. 2015;23(7):2165\u201374.","journal-title":"Support Care Cancer"},{"issue":"1","key":"165_CR61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12974-017-0796-7","volume":"14","author":"ME Roerink","year":"2017","unstructured":"Roerink ME, et al. Interleukin-1 as a mediator of fatigue in disease: a narrative review. J Neuroinflammation. 2017;14(1):16.","journal-title":"J Neuroinflammation"},{"key":"165_CR62","doi-asserted-by":"publisher","unstructured":"Gouasmi R, Ferraro-Peyret C, Nancey S, Coste I, Renno T, Chaveroux C, Aznar N, Ansieau S. The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated. Cancers (Basel). 2022;14(11):2793. https:\/\/doi.org\/10.3390\/cancers14112793.","DOI":"10.3390\/cancers14112793"},{"issue":"4","key":"165_CR63","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/1099800420938141","volume":"22","author":"H Li","year":"2020","unstructured":"Li H, et al. Systematic Review of the Kynurenine Pathway and Psychoneurological Symptoms Among Adult Cancer Survivors. Biol Res Nurs. 2020;22(4):472\u201384.","journal-title":"Biol Res Nurs"},{"key":"165_CR64","doi-asserted-by":"publisher","unstructured":"Gallicchio L, Tonorezos E, de Moor JS, Elena J, Farrell M, Green P, Mitchell SA, Mollica MA, Perna F, Saiontz NG, Zhu L, Rowland J, Mayer DK. Evidence Gaps in Cancer Survivorship Care: A Report From the 2019 National Cancer Institute Cancer Survivorship Workshop. J Natl Cancer Inst. 2021;113(9):1136\u201342. https:\/\/doi.org\/10.1093\/jnci\/djab049.","DOI":"10.1093\/jnci\/djab049"},{"key":"165_CR65","doi-asserted-by":"publisher","unstructured":"van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, Taphoorn MJ, Aaronson NK. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer. 2011;47(5):667\u201375. https:\/\/doi.org\/10.1016\/j.ejca.2010.11.004.","DOI":"10.1016\/j.ejca.2010.11.004"},{"key":"165_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejca.2016.09.020","volume":"69","author":"F Mols","year":"2016","unstructured":"Mols F, et al. Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population. Eur J Cancer. 2016;69:28\u201338.","journal-title":"Eur J Cancer"},{"key":"165_CR67","doi-asserted-by":"publisher","unstructured":"Mols F, Husson O, Oudejans M, Vlooswijk C, Horevoorts N, van de Poll-Franse LV. Reference data of the EORTC QLQ-C30 questionnaire: five consecutive annual assessments of approximately 2000 representative Dutch men and women. Acta Oncol. 2018;57(10):1381\u201391. https:\/\/doi.org\/10.1080\/0284186X.2018.1481293.","DOI":"10.1080\/0284186X.2018.1481293"},{"key":"165_CR68","doi-asserted-by":"publisher","unstructured":"van de Poll-Franse LV, Horevoorts N, Schoormans D, Beijer S, Ezendam NPM, Husson O, Oerlemans S, Schagen SB, Hageman GJ, Van Deun K, van den Hurk C, van Eenbergen M, Mols F; PROFILES Registry Group. Measuring Clinical, Biological, and Behavioral Variables to Elucidate Trajectories of Patient-Reported Outcomes: The PROFILES Registry. J Natl Cancer Inst. 2022;114(6):800\u20137. https:\/\/doi.org\/10.1093\/jnci\/djac047.","DOI":"10.1093\/jnci\/djac047"},{"key":"165_CR69","unstructured":"Eetmeter. The Netherlands Nutrition Centre, the Hague [cited 2019; Available from: https:\/\/mijn.voedingscentrum.nl\/nl\/eetmeter\/."},{"key":"165_CR70","unstructured":"Dutch Food Composition Database (NEVO). . National Institute for Public Health and the Environment (RIVM), Bilthoven NEVO online version 2016\/5.0; Available from: https:\/\/nevo-online.rivm.nl\/."},{"key":"165_CR71","unstructured":"NEVO-online 2016: background information Dutch Food Composition Database 2016. . National Institute for Public Health and the Environment (RIVM), Bilthoven, 2016; Available from: https:\/\/www.rivm.nl\/sites\/default\/files\/2018-11\/NEVO%20online%202016.%20Background%20information_final_13-9-2016.pdf."},{"issue":"5","key":"165_CR72","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.clnu.2004.06.004","volume":"23","author":"UG Kyle","year":"2004","unstructured":"Kyle UG, et al. Bioelectrical impedance analysis\u2013part I: review of principles and methods. Clin Nutr. 2004;23(5):1226\u201343.","journal-title":"Clin Nutr"},{"issue":"4","key":"165_CR73","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s40520-016-0622-6","volume":"29","author":"G Sergi","year":"2017","unstructured":"Sergi G, et al. Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons. Aging Clin Exp Res. 2017;29(4):591\u20137.","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"165_CR74","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"165_CR75","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/ERC-16-0530","volume":"24","author":"S Singer","year":"2017","unstructured":"Singer S, et al. The EORTC module for quality of life in patients with thyroid cancer: phase III. Endocr Relat Cancer. 2017;24(4):197\u2013207.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"165_CR76","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"165_CR77","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets EM, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315\u201325.","journal-title":"J Psychosom Res"},{"issue":"2","key":"165_CR78","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193\u2013213.","journal-title":"Psychiatry Res"},{"issue":"2","key":"165_CR79","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.2044-8287.2011.02046.x","volume":"17","author":"H Glaesmer","year":"2012","unstructured":"Glaesmer H, et al. Psychometric properties and population-based norms of the Life Orientation Test Revised (LOT-R). Br J Health Psychol. 2012;17(2):432\u201345.","journal-title":"Br J Health Psychol"},{"issue":"2","key":"165_CR80","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/art.10993","volume":"49","author":"O Sangha","year":"2003","unstructured":"Sangha O, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156\u201363.","journal-title":"Arthritis Rheum"},{"issue":"28","key":"165_CR81","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.1200\/JCO.2005.12.514","volume":"23","author":"M Brundage","year":"2005","unstructured":"Brundage M, et al. Communicating quality of life information to cancer patients: a study of six presentation formats. J Clin Oncol. 2005;23(28):6949\u201356.","journal-title":"J Clin Oncol"},{"issue":"3","key":"165_CR82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11136-015-1107-3","volume":"25","author":"W Kuijpers","year":"2016","unstructured":"Kuijpers W, et al. Patients\u2019 and health professionals\u2019 understanding of and preferences for graphical presentation styles for individual-level EORTC QLQ-C30 scores. Qual Life Res. 2016;25(3):595\u2013604.","journal-title":"Qual Life Res"},{"issue":"8","key":"165_CR83","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.7079","volume":"19","author":"S Oerlemans","year":"2017","unstructured":"Oerlemans S, et al. \u201cAm I normal?\u201d The Wishes of Patients With Lymphoma to Compare Their Patient-Reported Outcomes With Those of Their Peers. J Med Internet Res. 2017;19(8): e288.","journal-title":"J Med Internet Res"},{"key":"165_CR84","doi-asserted-by":"crossref","unstructured":"Clouth FJ, et al. Heterogeneity in Quality of Life of Long-Term Colon Cancer Survivors: A Latent Class Analysis of the Population-Based PROFILES Registry. Oncologist. 2021;26(3):e492\u2013e499.","DOI":"10.1002\/onco.13655"},{"issue":"17","key":"165_CR85","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1093\/bioinformatics\/bty1054","volume":"35","author":"A Singh","year":"2019","unstructured":"Singh A, et al. DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays. Bioinformatics. 2019;35(17):3055\u201362.","journal-title":"Bioinformatics"},{"issue":"1","key":"165_CR86","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12859-018-2114-5","volume":"19","author":"K Van Deun","year":"2018","unstructured":"Van Deun K, Crompvoets EAV, Ceulemans E. Obtaining insights from high-dimensional data: sparse principal covariates regression. BMC Bioinformatics. 2018;19(1):104.","journal-title":"BMC Bioinformatics"},{"key":"165_CR87","doi-asserted-by":"publisher","unstructured":"Leeuw, L.d.D. Data Seal of Approval (DSA). . 2019; Available from: https:\/\/doi.org\/10.17026\/dans-28z-njxq.","DOI":"10.17026\/dans-28z-njxq"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-023-00165-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-023-00165-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-023-00165-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T21:43:40Z","timestamp":1729719820000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/s13044-023-00165-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["165"],"URL":"https:\/\/doi.org\/10.1186\/s13044-023-00165-5","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"21 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WaTCh received approval from the \u2018Medisch Ethische Toetsingscommissie Brabant\u2019 (NL65161.028.18). In addition, the study has been reviewed and approved by the local ethics committees of the participating centers. All participants will provide written informed consent prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}